Tudor Investment Corp
RETA

Tudor Investment Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Tudor Investment Corp’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,760
Closed -$1.98M – 3058
2023
Q1 		$1.98M Buy
+21,760
New +$1.28M 0.03% 791
2022
Q4 		– Sell
-11,833
Closed -$297K – 2970
2022
Q3 		$297K Buy
11,833
+302
+3% +$8.37K 0.01% 1801
2022
Q2 		$350K Sell
11,531
-1,644
-12% -$49K 0.01% 1478
2022
Q1 		$432K Buy
13,175
+4,293
+48% +$127K 0.01% 1357
2021
Q4 		$234K Sell
8,882
-11,102
-56% -$859K ﹤0.01% 2045
2021
Q3 		$2.01M Buy
19,984
+4,360
+28% +$511K 0.03% 697
2021
Q2 		$2.21M Sell
15,624
-6,461
-29% -$730K 0.04% 518
2021
Q1 		$2.2M Buy
22,085
+8,859
+67% +$1.03M 0.04% 482
2020
Q4 		$1.64M Buy
+13,226
New +$1.74M 0.05% 497
2020
Q3 		– Sell
-7,666
Closed -$1.2M – 1602
2020
Q2 		$1.2M Buy
7,666
+1,740
+29% +$265K 0.06% 421
2020
Q1 		$855K Sell
5,926
-2,340
-28% -$452K 0.08% 296
2019
Q4 		$1.69M Buy
+8,266
New +$1.51M 0.08% 342

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's RETA Position: Q2 2023 in Review

Tudor Investment Corp sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2023, closing a stake of 21,760 shares — an estimated $1.98M sold.

Tudor Investment Corp first reported a position in RETA in Q4 2019 and held it in 12 quarters. The position peaked at $2.21M in Q2 2021. 214 funds tracked by Wall St. Rank hold RETA as of Q2 2023.

  • Tudor Investment Corp reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 21,760 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.98M.
  • Tudor Investment Corp first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 12 quarters.
  • Tudor Investment Corp's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.21M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.